CM
CRBP icon

Caption Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Caption Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Buy
27,852
+21,382
+330% +$202K ﹤0.01% 1434
2026
Q1 		$60.8K Sell
6,470
-49,596
-88% -$418K ﹤0.01% 1419
2025
Q4 		$456K Buy
+56,066
New +$692K ﹤0.01% 1257
2021
Q3 		– Sell
-8,960
Closed -$492K – 1549
2021
Q2 		$492K Buy
+8,960
New +$497K 0.01% 1042

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Caption Management's CRBP Position: Q2 2026 in Review

Caption Management increased its Corbus Pharmaceuticals (CRBP) stake by 330% in Q2 2026, buying an estimated $202K and bringing the position to 27,852 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #1434.

Caption Management first reported a position in CRBP in Q2 2021 and has held it in 4 quarters since. The position peaked at $492K in Q2 2021. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Caption Management held 27,852 shares of Corbus Pharmaceuticals worth $261K as of Q2 2026.
  • Caption Management bought 21,382 Corbus Pharmaceuticals shares in Q2 2026, an estimated $202K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1434 holding.
  • Caption Management first reported a position in Corbus Pharmaceuticals in Q2 2021 and has held it in 4 quarters since.
  • Caption Management's Corbus Pharmaceuticals position peaked at $492K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.